APO Research
Talk to an analyst

APO RESEARCH · REPORT

Emphysema Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Emphysema Drug Industry Growth and Trends Forecast to 2032

26 December 202593 pages

Choose your research edition.

Industry ResearchEmphysema Drug Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Emphysema Drug Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Emphysema Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Emphysema Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Emphysema Drug Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Emphysema Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Emphysema Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Emphysema Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Emphysema Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Emphysema Drug include Angion Biomedica Corp., ProMetic Life Sciences Inc., rEVO Biologics, Inc., SATT North SAS and TGV-Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Emphysema Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Emphysema Drug market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Emphysema Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Emphysema Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Emphysema Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Emphysema Drug Market by Company

Angion Biomedica Corp.

ProMetic Life Sciences Inc.

rEVO Biologics, Inc.

SATT North SAS

TGV-Laboratories

Emphysema Drug Segment by Type

MG-53

EDO-66

BB-3

Others

Emphysema Drug Segment by Application

Hospital

Clinic

Others

Emphysema Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Emphysema Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Emphysema Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Emphysema Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Emphysema Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Emphysema Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of MG-53 Table 2. Major Company of EDO-66 Table 3. Major Company of BB-3 Table 4. Major Company of Others Table 5. Global Emphysema Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Emphysema Drug Sales by Type (2021-2026) & (W Units) Table 7. Global Emphysema Drug Sales Market Share in Volume by Type (2021-2026) Table 8. Global Emphysema Drug Sales by Type (2021-2026) & (US$ Million) Table 9. Global Emphysema Drug Sales Market Share in Value by Type (2021-2026) Table 10. Global Emphysema Drug Price by Type (2021-2026) & (US$/Unit) Table 11. Global Emphysema Drug Sales by Type (2027-2032) & (W Units) Table 12. Global Emphysema Drug Sales Market Share in Volume by Type (2027-2032) Table 13. Global Emphysema Drug Sales by Type (2027-2032) & (US$ Million) Table 14. Global Emphysema Drug Sales Market Share in Value by Type (2027-2032) Table 15. Global Emphysema Drug Price by Type (2027-2032) & (US$/Unit) Table 16. North America Emphysema Drug Sales by Type (2021-2026) & (W Units) Table 17. North America Emphysema Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Emphysema Drug Sales by Type (2021-2026) & (W Units) Table 19. Europe Emphysema Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Emphysema Drug Sales by Type (2021-2026) & (W Units) Table 21. Asia-Pacific Emphysema Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Emphysema Drug Sales by Type (2021-2026) & (W Units) Table 23. Latin America Emphysema Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Emphysema Drug Sales by Type (2021-2026) & (W Units) Table 25. Middle East and Africa Emphysema Drug Sales by Type (2021-2026) & (US$ Million) Table 26. Emphysema Drug Industry Trends Table 27. Emphysema Drug Industry Drivers Table 28. Emphysema Drug Industry Opportunities and Challenges Table 29. Emphysema Drug Industry Restraints Table 30. Global Emphysema Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Emphysema Drug Revenue Market Share by Company (2021-2026) Table 32. Global Emphysema Drug Sales by Company (2021-2026) & (W Units) Table 33. Global Emphysema Drug Sales Share by Company (2021-2026) Table 34. Global Emphysema Drug Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Emphysema Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Emphysema Drug Major Company Production Sites and Headquarters Table 37. Global Emphysema Drug Company, Product Type & Application Table 38. Global Emphysema Drug Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Emphysema Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Emphysema Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Emphysema Drug Sales by Region (2021-2026) & (W Units) Table 43. Global Emphysema Drug Sales Market Share in Volume by Region (2021-2026) Table 44. Global Emphysema Drug Sales by Region (2021-2026) & (US$ Million) Table 45. Global Emphysema Drug Sales Market Share in Value by Region (2021-2026) Table 46. Global Emphysema Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Emphysema Drug Sales by Region (2027-2032) & (W Units) Table 48. Global Emphysema Drug Sales Market Share in Volume by Region (2027-2032) Table 49. Global Emphysema Drug Sales by Region (2027-2032) & (US$ Million) Table 50. Global Emphysema Drug Sales Market Share in Value by Region (2027-2032) Table 51. Global Emphysema Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Emphysema Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Emphysema Drug Sales by Application (2021-2026) & (W Units) Table 54. Global Emphysema Drug Sales Market Share in Volume by Application (2021-2026) Table 55. Global Emphysema Drug Sales by Application (2021-2026) & (US$ Million) Table 56. Global Emphysema Drug Sales Market Share in Value by Application (2021-2026) Table 57. Global Emphysema Drug Price by Application (2021-2026) & (US$/Unit) Table 58. Global Emphysema Drug Sales by Application (2027-2032) & (W Units) Table 59. Global Emphysema Drug Sales Market Share in Volume by Application (2027-2032) Table 60. Global Emphysema Drug Sales by Application (2027-2032) & (US$ Million) Table 61. Global Emphysema Drug Sales Market Share in Value by Application (2027-2032) Table 62. Global Emphysema Drug Price by Application (2027-2032) & (US$/Unit) Table 63. North America Emphysema Drug Sales by Application (2021-2026) & (W Units) Table 64. North America Emphysema Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Emphysema Drug Sales by Application (2021-2026) & (W Units) Table 66. Europe Emphysema Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Emphysema Drug Sales by Application (2021-2026) & (W Units) Table 68. Asia-Pacific Emphysema Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Emphysema Drug Sales by Application (2021-2026) & (W Units) Table 70. Latin America Emphysema Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Emphysema Drug Sales by Application (2021-2026) & (W Units) Table 72. Middle East and Africa Emphysema Drug Sales by Application (2021-2026) & (US$ Million) Table 73. Angion Biomedica Corp. Company Information Table 74. Angion Biomedica Corp. Business Overview Table 75. Angion Biomedica Corp. Emphysema Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Angion Biomedica Corp. Emphysema Drug Product Portfolio Table 77. Angion Biomedica Corp. Recent Development Table 78. ProMetic Life Sciences Inc. Company Information Table 79. ProMetic Life Sciences Inc. Business Overview Table 80. ProMetic Life Sciences Inc. Emphysema Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. ProMetic Life Sciences Inc. Emphysema Drug Product Portfolio Table 82. ProMetic Life Sciences Inc. Recent Development Table 83. rEVO Biologics, Inc. Company Information Table 84. rEVO Biologics, Inc. Business Overview Table 85. rEVO Biologics, Inc. Emphysema Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. rEVO Biologics, Inc. Emphysema Drug Product Portfolio Table 87. rEVO Biologics, Inc. Recent Development Table 88. SATT North SAS Company Information Table 89. SATT North SAS Business Overview Table 90. SATT North SAS Emphysema Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. SATT North SAS Emphysema Drug Product Portfolio Table 92. SATT North SAS Recent Development Table 93. TGV-Laboratories Company Information Table 94. TGV-Laboratories Business Overview Table 95. TGV-Laboratories Emphysema Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. TGV-Laboratories Emphysema Drug Product Portfolio Table 97. TGV-Laboratories Recent Development Table 98. North America Emphysema Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 99. North America Emphysema Drug Sales by Country (2021-2026) & (W Units) Table 100. North America Emphysema Drug Sales Market Share by Country (2021-2026) Table 101. North America Emphysema Drug Sales Forecast by Country (2027-2032) & (W Units) Table 102. North America Emphysema Drug Sales Market Share Forecast by Country (2027-2032) Table 103. North America Emphysema Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America Emphysema Drug Market Size by Country (2021-2026) & (US$ Million) Table 105. North America Emphysema Drug Market Share by Country (2021-2026) Table 106. North America Emphysema Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America Emphysema Drug Market Share Forecast by Country (2027-2032) Table 108. Europe Emphysema Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 109. Europe Emphysema Drug Sales by Country (2021-2026) & (W Units) Table 110. Europe Emphysema Drug Sales Market Share by Country (2021-2026) Table 111. Europe Emphysema Drug Sales Forecast by Country (2027-2032) & (W Units) Table 112. Europe Emphysema Drug Sales Market Share Forecast by Country (2027-2032) Table 113. Europe Emphysema Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Europe Emphysema Drug Market Size by Country (2021-2026) & (US$ Million) Table 115. Europe Emphysema Drug Market Share by Country (2021-2026) Table 116. Europe Emphysema Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Europe Emphysema Drug Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific Emphysema Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific Emphysema Drug Sales by Country (2021-2026) & (W Units) Table 120. Asia-Pacific Emphysema Drug Sales Market Share by Country (2021-2026) Table 121. Asia-Pacific Emphysema Drug Sales Forecast by Country (2027-2032) & (W Units) Table 122. Asia-Pacific Emphysema Drug Sales Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Emphysema Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Emphysema Drug Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific Emphysema Drug Market Share by Country (2021-2026) Table 126. Asia-Pacific Emphysema Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific Emphysema Drug Market Share Forecast by Country (2027-2032) Table 128. Latin America Emphysema Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 129. Latin America Emphysema Drug Sales by Country (2021-2026) & (W Units) Table 130. Latin America Emphysema Drug Sales Market Share by Country (2021-2026) Table 131. Latin America Emphysema Drug Sales Forecast by Country (2027-2032) & (W Units) Table 132. Latin America Emphysema Drug Sales Market Share Forecast by Country (2027-2032) Table 133. Latin America Emphysema Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America Emphysema Drug Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America Emphysema Drug Market Share by Country (2021-2026) Table 136. Latin America Emphysema Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America Emphysema Drug Market Share Forecast by Country (2027-2032) Table 138. Middle East and Africa Emphysema Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 139. Middle East and Africa Emphysema Drug Sales by Country (2021-2026) & (W Units) Table 140. Middle East and Africa Emphysema Drug Sales Market Share by Country (2021-2026) Table 141. Middle East and Africa Emphysema Drug Sales Forecast by Country (2027-2032) & (W Units) Table 142. Middle East and Africa Emphysema Drug Sales Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa Emphysema Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa Emphysema Drug Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East and Africa Emphysema Drug Market Share by Country (2021-2026) Table 146. Middle East and Africa Emphysema Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Emphysema Drug Market Share Forecast by Country (2027-2032) Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Emphysema Drug Distributors List Table 151. Emphysema Drug Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Emphysema Drug Image Figure 2. Global Emphysema Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Emphysema Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Emphysema Drug Sales (2021-2032) & (W Units) Figure 5. MG-53 Image Figure 6. Global MG-53 Sales YoY Growth (2021-2032) & (W Units) Figure 7. EDO-66 Image Figure 8. Global EDO-66 Sales YoY Growth (2021-2032) & (W Units) Figure 9. BB-3 Image Figure 10. Global BB-3 Sales YoY Growth (2021-2032) & (W Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 13. Global Emphysema Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Emphysema Drug Market Share by Type 2025 VS 2032 Figure 15. North America Emphysema Drug Sales Market Share in Volume by Type in 2025 Figure 16. North America Emphysema Drug Sales Market Share in Value by Type in 2025 Figure 17. Europe Emphysema Drug Sales Market Share in Volume by Type in 2025 Figure 18. Europe Emphysema Drug Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Emphysema Drug Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Emphysema Drug Sales Market Share in Value by Type in 2025 Figure 21. Latin America Emphysema Drug Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Emphysema Drug Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Emphysema Drug Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Emphysema Drug Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Emphysema Drug Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (W Units) Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (W Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 33. Global Emphysema Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Emphysema Drug Market Share by Application 2025 VS 2032 Figure 35. North America Emphysema Drug Sales Market Share in Volume by Application in 2025 Figure 36. North America Emphysema Drug Sales Market Share in Value by Application in 2025 Figure 37. Europe Emphysema Drug Sales Market Share in Volume by Application in 2025 Figure 38. Europe Emphysema Drug Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Emphysema Drug Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Emphysema Drug Sales Market Share in Value by Application in 2025 Figure 41. Latin America Emphysema Drug Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Emphysema Drug Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Emphysema Drug Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Emphysema Drug Sales Market Share in Value by Application in 2025 Figure 45. North America Emphysema Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 46. North America Emphysema Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Emphysema Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Emphysema Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Emphysema Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. Europe Emphysema Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Emphysema Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Emphysema Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Emphysema Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Asia-Pacific Emphysema Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Emphysema Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Emphysema Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Emphysema Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Latin America Emphysema Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Emphysema Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Emphysema Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Emphysema Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 62. Middle East and Africa Emphysema Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Emphysema Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Emphysema Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Emphysema Drug Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Emphysema Drug Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • MG-53
  • EDO-66
  • BB-3
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Angion Biomedica Corp.
  • ProMetic Life Sciences Inc.
  • rEVO Biologics, Inc.
  • SATT North SAS
  • TGV-Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Emphysema Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Emphysema Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Emphysema Drug Market by Type
  6. 1.3.1 MG-53
  7. 1.3.2 EDO-66
  8. 1.3.3 BB-3
  9. 1.3.4 Others
  10. 1.4 Global Emphysema Drug Market Size by Type
  11. 1.4.1 Global Emphysema Drug Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Emphysema Drug Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Emphysema Drug Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Emphysema Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Emphysema Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Emphysema Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Emphysema Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Emphysema Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Emphysema Drug Industry Trends
  2. 2.2 Emphysema Drug Industry Drivers
  3. 2.3 Emphysema Drug Industry Opportunities and Challenges
  4. 2.4 Emphysema Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Emphysema Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Emphysema Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Emphysema Drug Price (2021-2026)
  4. 3.4 Global Emphysema Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Emphysema Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Emphysema Drug Company, Product Type & Application
  7. 3.7 Global Emphysema Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Emphysema Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Emphysema Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Emphysema Drug Tier 1, Tier 2, and Tier 3
4 Emphysema Drug Regional Status and Outlook
  1. 4.1 Global Emphysema Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Emphysema Drug Historic Market Size by Region
  3. 4.2.1 Global Emphysema Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Emphysema Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Emphysema Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Emphysema Drug Forecasted Market Size by Region
  7. 4.3.1 Global Emphysema Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Emphysema Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Emphysema Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Emphysema Drug by Application
  1. 5.1 Emphysema Drug Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Emphysema Drug Market Size by Application
  6. 5.2.1 Global Emphysema Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Emphysema Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Emphysema Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Emphysema Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Emphysema Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Emphysema Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Emphysema Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Emphysema Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Angion Biomedica Corp.
  2. 6.1.1 Angion Biomedica Corp. Company Information
  3. 6.1.2 Angion Biomedica Corp. Business Overview
  4. 6.1.3 Angion Biomedica Corp. Emphysema Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Angion Biomedica Corp. Emphysema Drug Product Portfolio
  6. 6.1.5 Angion Biomedica Corp. Recent Developments
  7. 6.2 ProMetic Life Sciences Inc.
  8. 6.2.1 ProMetic Life Sciences Inc. Company Information
  9. 6.2.2 ProMetic Life Sciences Inc. Business Overview
  10. 6.2.3 ProMetic Life Sciences Inc. Emphysema Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 ProMetic Life Sciences Inc. Emphysema Drug Product Portfolio
  12. 6.2.5 ProMetic Life Sciences Inc. Recent Developments
  13. 6.3 rEVO Biologics, Inc.
  14. 6.3.1 rEVO Biologics, Inc. Company Information
  15. 6.3.2 rEVO Biologics, Inc. Business Overview
  16. 6.3.3 rEVO Biologics, Inc. Emphysema Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 rEVO Biologics, Inc. Emphysema Drug Product Portfolio
  18. 6.3.5 rEVO Biologics, Inc. Recent Developments
  19. 6.4 SATT North SAS
  20. 6.4.1 SATT North SAS Company Information
  21. 6.4.2 SATT North SAS Business Overview
  22. 6.4.3 SATT North SAS Emphysema Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 SATT North SAS Emphysema Drug Product Portfolio
  24. 6.4.5 SATT North SAS Recent Developments
  25. 6.5 TGV-Laboratories
  26. 6.5.1 TGV-Laboratories Company Information
  27. 6.5.2 TGV-Laboratories Business Overview
  28. 6.5.3 TGV-Laboratories Emphysema Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 TGV-Laboratories Emphysema Drug Product Portfolio
  30. 6.5.5 TGV-Laboratories Recent Developments
7 North America by Country
  1. 7.1 North America Emphysema Drug Sales by Country
  2. 7.1.1 North America Emphysema Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Emphysema Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Emphysema Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Emphysema Drug Market Size by Country
  6. 7.2.1 North America Emphysema Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Emphysema Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Emphysema Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Emphysema Drug Sales by Country
  2. 8.1.1 Europe Emphysema Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Emphysema Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Emphysema Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Emphysema Drug Market Size by Country
  6. 8.2.1 Europe Emphysema Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Emphysema Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Emphysema Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Emphysema Drug Sales by Country
  2. 9.1.1 Asia-Pacific Emphysema Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Emphysema Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Emphysema Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Emphysema Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Emphysema Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Emphysema Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Emphysema Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Emphysema Drug Sales by Country
  2. 10.1.1 South America Emphysema Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Emphysema Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Emphysema Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Emphysema Drug Market Size by Country
  6. 10.2.1 South America Emphysema Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Emphysema Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Emphysema Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Emphysema Drug Sales by Country
  2. 11.1.1 Middle East and Africa Emphysema Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Emphysema Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Emphysema Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Emphysema Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Emphysema Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Emphysema Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Emphysema Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Emphysema Drug Value Chain Analysis
  2. 12.1.1 Emphysema Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Emphysema Drug Production Mode & Process
  7. 12.2 Emphysema Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Emphysema Drug Distributors
  10. 12.2.3 Emphysema Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst